tbuckley/cabot-search huggingface dataset:
Unit of Measure Incorrect
Journal: JAMA (1972)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Approach to Risk Assessment for Genotoxic Carcinogens Based on Data from the Mouse Skin Initiation-Promotion Model
Authors: F. Burns, R. Albert, B. Altshuler, E. Morris
Journal: Environmental Health Perspectives (1983)

Tumor induction data in the mouse skin initiation-promotion system were found to be consistent with a quadratic function where the coefficient of the linear term depended on the dose of the promoter. The model implies that the existence of promoters may be more important at low doses of the carcinogen than at high doses where most testing is performed. Experiments are described showing that the initiating effect of carcinogenic chemicals, such as benzo(a)pyrene, 7,12-dimethyl-benz(a)anthracene, nitroquinoline oxide and beta-propiolactone, accumulates in a linear, irreversible manner at low doses. Even when 7,12-dimethylbenz(a)anthracene was applied intragastrically to pregnant females, initiating activity was found in the skins of exposed offspring about in proportion to dose applied and number of cells at risk. The initiated cells essentially represent a potential for cancer that has a high probability for expression in the presence of a promoter. Risk then can be interpreted in terms of the accumulated dose of initiator which alone presents a small risk of cancer. However, a promoter may substantially expand the overall risk, possibly by clonally expanding the initiated cells. Promotion needs to be sustained since there is a reduction of cancer risk if promotion is ended early. Some tissues, such as mouse bladder, may be intrinsically promoted more than others so that comparisons between tissues and between species are best made when the combination of intrinsic promotion and response to extrinsic promotion are comparable.
Erratum: Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11
Authors: Henry Houlden, Janel Johnson, Christopher Gardner-Thorpe, Tammaryn Lashley, Dena Hernandez, Paul Worth, Andrew B Singleton, David A Hilton, Janice Holton, Tamas Revesz, Mary B Davis, Paolo Giunti, Nicholas W Wood
Journal: Nature Genetics (2008)
Postgraduate Studies on Immunovirology of Cancer
Journal: JNCI Journal of the National Cancer Institute (1974)

Journal Article Postgraduate Studies on Immunovirology of Cancer Get access JNCI: Journal of the National Cancer Institute, Volume 52, Issue 5, May 1974, Page 1679, https://doi.org/10.1093/jnci/52.5.1679-d Published: 01 May 1974
An Address Delivered at the Opening of the Section of Obstetric Medicine
Authors: G. Hewitt
Journal: BMJ (1883)

THE PR1TISH MEDICAL JTO UJNAL.ILAug. 4,188& but where is the individual life in disease ?Inmy humble opinion, the germ will not serve our purpose, for, according to the great Darwinian analogy, the germ is always a part of the individual, and always presupposes the individual.The germ, or the sperm, is no doubt a peculiarly important part, and it is charged with the most marvellous representative powers; but it is always represen- tative of the individual, and it derives its powers from the indi- vidual.Such, at least, is our only analogy.If, then, we must have the individual to start with, before we can apply the "origin of species" to disease, we come back to the old question, how a morbid state of the body canbecome a semi-indepen- dent thing, how it can exist, not in absolute independence of the body, but autonomous within it, an imperium in imperio.This is the perplexing question which I stated at the outset with reference to cancer, a disease which, in the popular estimation is almost synonymous with a semi-independent life, and I quoted the words of Paracelsus: " In such a disease, a man is himself and another; he has two bodies at one time, enclosed the one in the other, and yet he is one man."Ihave spokentoseveral metaphysicalfriendsofthe difficulty of conceiving how a mere state of the body, a complex or integrated morbid state, can become an individual existence with the power of propagating itself; but I cannot say that I have got any- thing satisfactory out of them.We shall probably bave to settle this question within our own science as a part of the subject-matter of pathology.Pathology is indeed varied enough in its subject- matter.It studies disease on many sides, as the founder of this As- sociation planned that it should be studied-the side of its anatomy and its physiology, of its geography and its ethnology, of its history and its natural history.Its aspects are as various and at- tractive as the fruit trees in the Mohammedan paradise.But there is nothing in all this boundless field of inquiry that is more likely to occupy the mind of the profession for years to come, as it has occupied it in timespast, than the difficulty for conceiving how a state or condition of the body can become a species of disease.
Erratum
Journal: BMJ (1901)

ASSISTANT asks wuhat demand tlherc is for assistants in the Colonlies (as Australia New Zca,ilaiid, ol Cape Colony) and wliat salary they get as compared with a. hx0onic assistantship.TINNITus AURIUM.BETA asks for s;uggestionis for the relief of tinnitus in a case of sclerosis of the middle ear, wvith soniie inivolveimient of the labyrinth; the ordinary remedies-bromllides, conistant current, inflation-have been tried with signal non-Silcecss.
Medical Education, Registration and Hospital Service
Journal: JAMA (1929)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hazardous-Waste Sites: Priority Health Conditions and Research Strategies—United States
Journal: JAMA (1992)

Uncontrolled disposal sites containing hazardous waste and other contaminants have created national environmental problems (1). Because of potential health problems associated with the more than 33,000 hazardous-waste sites in the United States, the Agency for Toxic Substances and Disease Registry (ATSDR)--as part of its federally legislated mandate--has developed a list of seven priority health conditions (PHCs) to 1) assist in evaluating potential health risks to persons living near these sites and 2) determine program and applied human health research activities involving hazardous substances identified at the sites. This report summarizes the development and intended applications of the seven PHCs.
Travel Associated Legionnaires' Disease in Europe : 2003
Authors: K D Ricketts, C Joseph
Journal: Eurosurveillance (2004)

Six hundred and thirty two cases of travel-associated legionnaires' disease with onset in 2003 were reported to the EWGLINET surveillance scheme by 24 countries. Eighty nine clusters were detected, 35 (39%) of which would not have been detected without the EWGLINET scheme. One hundred and seven accommodation sites were investigated and 22 sites were published on the EWGLI website. The proportion of cases diagnosed primarily by the urinary antigen test was 81.2%, and 48 positive cultures were obtained. Thirty eight deaths were reported to the EWGLINET scheme, giving a crude fatality rate of 6%. Countries are encouraged to inform the coordinating centre of cases that fall ill after travelling within their own country of residence ('internal travel'), and are also encouraged to obtain patient isolates for culture where at all possible.
A Text-Book on the Pathogenic Bacteria and Protozoa.
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dear doctor ... regarding calcium channel blockers
Authors: D. B. Stryer
Journal: JAMA (1996)

<h3>In Reply.</h3> —Dr Blandino has suggested that "miscommunication" of nondefinitive data disparaged the use of diuretics initially. Nobody would disagree that reliable evidence of net benefits of drug treatment of mild to moderate hypertension on subsequent cardiovascular mortality, stroke, and myocardial infarction were derived from randomized trials primarily testing diuretics and β-blockers.<sup>1-3</sup>However, the stroke benefit is virtually identical to that predicted from meta-analysis of observational studies, whereas for myocardial infarction the benefit is about one-half to two-thirds that predicted. Both chance and a delayed effect on atherogenesis may explain this shortfall, but another plausible hypothesis is possible elevations of low-density lipoprotein cholesterol by about 5%, which could increase risk of myocardial infarction by 15%. Thus, randomized trial data are needed to provide reliable evidence on the balance of risks and benefits of all these agents. Dr Blandino and Drs Cooper and Freeman question the degree of clinical certainty
Cardiac defibrillation by ambulance attendants
Authors: L. B. Rose
Journal: JAMA (1972)

Defibrillation by ambulance attendants was the goal of the Oregon Coronary Ambulance Project organized in 1969 by the Oregon State Board of Health in cooperation with a private ambulance company, a community hospital, and the county medical society. Highly motivated ambulance personnel were trained so that they achieved a high degree of accuracy in the interpretation of life-threatening electrocardiographic arrhythmias, and by persistent vigorous cardiopulmonary resuscitation combined with defibrillation were able to salvage seven out of 14 patients, without telemetry, all of whom were subsequently discharged from the hospital. The feasibility of incorporating this service on a practical basis into the community medical system with conservation of medical manpower and at a low cost to the patient was demonstrated.
Outpatient Clinic: Where is the Delay?
Authors: H R H Patel, C N Luxman, T S Bailey, J D M Brunning, D Zemmel, L K Morrell, M S Nathan, R A Miller
Journal: Journal of the Royal Society of Medicine (2002)

In outpatient clinics, consultation times are often eroded by extraneous activities. We measured the components of each outpatient episode in 167 patients attending a general urology follow-up clinic. 41% of time in the clinic was spent away from the patient—administration 17%, disturbances 15%, finding results 9%. The inefficiencies had changed little since a study in the same setting thirteen years earlier. Since then, parallel nurse-practitioner-run clinics have been introduced in the hope of giving consultants longer with the patient; however, time with each patient is now 4.8 min compared with a previous 7.6 min. The most easily addressed inefficiencies are those relating to missing information, such as radiology reports.
Medical State Board Examinations: Topical Summaries and Answers. An Organized Review of Actual Questions Given in Medical Licensing Examinations Throughout the United States.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Harassment
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Patient-reported symptoms and impact in non-alcoholic steatohepatitis: an evaluation of the NASH-check, a novel prom in NASH
Authors: Diane Whalley, James Twiss, Lynda Doward, Maria Magdalena Balp, Clifford Brass, Juergen Loeffler, Patricia Lopez, Jennifer Cai, Donna Cryer, Quentin Anstee, Arun Sanyal
Journal: Journal of Hepatology (2020)
Rush Medical College Commencement Exercises.
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cisplatin Neurotoxicity
Authors: Joan E. Mollman
Journal: New England Journal of Medicine (1990)

Cisplatin is a chemotherapeutic agent that has dramatically altered the prognosis for patients with a variety of tumors. Its promise as an anticancer agent was recognized in the mid-1960s when Rosenberg et al.1 were studying the effects of electric fields on cellular growth. They noted that Escherichia coli grown in an apparatus containing platinum electrodes elongated but did not divide. This effect was found to be due to the production of cis-diamminedichloroplatinum, now commonly known as cisplatin, in the growth medium. In 1968, as the result of a leap of faith or intuition, investigators began to test cisplatin and . . .
Undeclared Corticosteroid
Authors: Rebecca Voelker
Journal: JAMA (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Triamcinolone and Hydrocortisone in Topical Therapy
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Metabolism Of Alpha- And Beta-Adrenergic Receptors In Vitro And In Vivo
Authors: L. Mahan
Journal: The Annual Review of Pharmacology and Toxicology (1987)

Heme oxygenases (HO) catabolize free heme, that is, iron (Fe) protoporphyrin (IX), into equimolar amounts of Fe2+, carbon monoxide (CO), and biliverdin. The stress-responsive HO-1 isoenzyme affords protection against programmed cell death. The mechanism ...Read More
Tuberculous Pericarditis.
Authors: Harold A. Lyons
Journal: Annals of Internal Medicine (1968)

s1 May 1968Tuberculous Pericarditis.Harold A. Lyons, M.D., F.A.C.P., John J. Rooney, M.D., John A. Crocco, M.D.Harold A. Lyons, M.D., F.A.C.P.Search for more papers by this author, John J. Rooney, M.D.Search for more papers by this author, John A. Crocco, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-68-5-1175_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTuberculous pericarditis remains a disease difficult to diagnose and is associated with a high mortality (40%). Treatment has never been formalized. In our experience with 32 patients having tuberculous pericarditis 7 (22%) failed to have a diagnosis antemortem. Of the remaining 25 patients 2 groups were compared, the first including 10 patients treated with triple therapy alone and the second, 15 patients treated with triple therapy and corticosteroids. Both groups were comparable as to age, race, sex, and extent and duration of disease. In the first group 4 of 10 patients died, and in the other there were no deaths.... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Brooklyn, New York PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByImmune reactions in tuberculous and chronic constrictive pericarditis 1 May 1968Volume 68, Issue 5Page: 1175-1175KeywordsCorticosteroid therapyMortalityRacial and ethnic issuesTuberculosis Issue Published: 1 May 1968 PDF DownloadLoading ...